Ventral targeted anterior capsulotomy for treatment-resistant depression and obsessive-compulsive disorder: A treatment method with cases

被引:1
|
作者
Hurwitz, Trevor A. [1 ,5 ]
Avecillas-Chasin, Josue M. [2 ]
Bogod, Nicholas M. [3 ]
Honey, Christopher R. [4 ]
机构
[1] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[2] Mt Sinai Hlth Syst, Dept Neurosurg, New York, NY USA
[3] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC, Canada
[4] Univ British Columbia, Dept Surg, Vancouver, BC, Canada
[5] Univ British Columbia, UBC Hosp, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada
关键词
Depression; Obsessive -compulsive disorder; Ablative surgery; Anterior capsulotomy; Case report; GUIDED FOCUSED ULTRASOUND; TERM-FOLLOW-UP; METHODOLOGICAL ISSUES; MAJOR DEPRESSION; OCD; PSYCHOSURGERY; NEUROSURGERY; INVENTORY; CIRCUITS; NUCLEUS;
D O I
10.1016/j.jad.2024.01.176
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Ablative surgery using bilateral anterior capsulotomy (BAC) is an option for treatment resistant depression (TRD) and obsessive-compulsive disorder (TROCD). The location and extent of the lesion within anterior limb of the internal capsule (ALIC) remains uncertain. Accumulating evidence has suggested that the lesion should be located ventrally while limiting the dorsal extent. Our center is now targeting specific fiber tracts within the lower half of the ALIC. Method: Presurgical diffusion tensor Magnetic Resonance Imaging (MRI) was used to identify individual fibre tracts within the ventral aspect of the ALIC in the last two patients who underwent BAC at our center. One patient had TRD and the other had both TROCD and TRD. Radiofrequency-induced thermal lesions were created in the identified targets with lesion volumes between 20 and 229 mm3 (average 95 mm3). Findings: Both patients were responders with neither experiencing significant side effects including compromised executive functions. Limitations: The generalizability of our findings is limited because the outcome is based on two subjects. Conclusion: This work suggests that BAC can be individually tailored and more limited to the ventral aspect of the ALIC and is effective and safe for TRD and TROCD. Accumulating data also suggests that to be clinically effective the length of the capsulotomy should be about 10mm. BAC's use may increase with the growing utilization and mastery of magnetic resonance guided focused ultrasound.
引用
收藏
页码:887 / 894
页数:8
相关论文
共 50 条
  • [1] Bilateral Anterior Capsulotomy for Treatment-Resistant Obsessive-Compulsive Disorder
    Hurwitz, Trevor
    Ching, Geoffrey
    Bogod, Nicholas Mark
    Honey, Christopher R.
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2024,
  • [2] Treatment-resistant obsessive-compulsive disorder
    Pallanti, S.
    Bernardi, S.
    Castellini, G.
    Quercioli, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S209 - S209
  • [3] Efficacy and Safety of Gamma Ventral Capsulotomy for Treatment-Resistant Obsessive-Compulsive Disorder: A Single-Center Experience
    Peker, Selcuk
    Samanci, Mustafa Yavuz
    Yilmaz, Meltem
    Sengoz, Meric
    Ulku, Nazan
    Ogel, Kultegin
    WORLD NEUROSURGERY, 2020, 141 : E941 - E952
  • [4] Quetiapine in treatment-resistant obsessive-compulsive disorder
    Cohen, LS
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (06): : 623 - 624
  • [5] Citalopram for treatment-resistant obsessive-compulsive disorder
    Pallanti, S
    Quercioli, L
    Paiva, RS
    Koran, LM
    EUROPEAN PSYCHIATRY, 1999, 14 (02) : 101 - 106
  • [6] Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Friedberg, J
    Wasserman, S
    Allen, A
    Birnbaum, M
    Koran, LM
    JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (05) : 546 - 550
  • [7] Management of Treatment-Resistant Obsessive-Compulsive Disorder
    Gershkovich M.
    Wheaton M.G.
    Simpson H.B.
    Current Treatment Options in Psychiatry, 2017, 4 (4) : 357 - 370
  • [8] Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder
    Kayser, Reilly R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
  • [9] Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Friedberg, J
    Wasserman, S
    Allen, A
    Koran, LM
    Birnbaum, M
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 206S - 207S
  • [10] Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder
    Koran, LM
    Ringold, AL
    Elliott, MA
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (07) : 514 - 517